Sfoglia per AUTORE
FOFI L
Collezione ASL Asti

  

Items : 7

Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study. in European journal of neurology / Eur J Neurol. 2022 Apr;29(4):1198-1208. doi: 10.1111/ene.15197. Epub 2021 Dec 6.

2022
ASL Asti

Cevoli S; Albanese M; Bono F; Colombo B; Ranieri A; Schiano Di Cola F; Finocchi C; Di Fiore P; Doretti A; Lovati C; Bertuzzo D; d'Onofrio F; Favoni V; Fofi L; Egeo G; Aurilia C; Costa CM; Barbanti P; Brunelli N; Altamura C; Vernieri F;

Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) in Journal of Headache and Pain

2021
ASL Asti

Alfieri G; Manzo L; Pascarella A; Baldi O; Di Cola FS; Messina S; Trogu F; Frediani F; Capogrosso C; Bertuzzo D; Spitaleri D; Cevoli S; Barbanti P; Bono F; Ranieri A; Albanese M; Doretti A; Di Fiore P; Finocchi C; Rao R; Lovati C; Aguggia M; d’Onofrio F; Favoni V; Pierangeli G; Aurilia C; Egeo G; Fofi L; Vernieri F; et alii...

Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: The early 2 study in Journal of the Neurological Sciences

2021
ASL Asti

Salerno A; Torelli P; Albanese M; Egeo G; Fofi L; Messina R; Aurilia C; Cevoli S; Barbanti P; Trimboli M; Pascarella A; Manzo L; Bertuzzo D; Zucco M; Di Clemente L; Costa CM; Brunelli N; Fallacara A; Favoni V; Finocchi C; Di Fiore P; D'Onofrio F; Grazzi L; Aguggia M; Colombo B; Frediani F; Mercuri B; D'Amico D; Filippi M; et alii...

Long-term (>48 weeks) safety and tolerability of erenumab in real-life in Journal of the Neurological Sciences

2021
ASL Asti

Pascarella A; Manzo L; Barbanti P; Zucco M; Di Clemente L; Trimboli M; Costa CM; Brunelli N; Fallacara A; Bertuzzo D; Favoni V; Finocchi C; Fiore PD; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Vernieri F; Colombo B; Frediani F; Bono F; D'Amico D; Filippi M; Altamura C; Torelli P; Albanese M; Carnevale A; Fofi L; Cevoli S; et alii...

Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Dec;41(Suppl 2):487-488. doi: 10.1007/s10072-020-04669-y.

2020
ASL Asti
ASL Vercelli

Cevoli S; Barbanti P; Albanese M; Frediani F; Di Fiore P; Bertuzzo D; Aguggia M; Fallacara A; Favoni V; Pierangeli G; Costa CM; Fofi L; Brunelli N; Vernieri F; Egeo G; Aurilia C; Altamura C;

New evidence from the italian chronic migraine registry (iron registry): An update on 866 patients in Neurology

2020
ASL Asti

Barbanti P; Fofi L; Egeo G; Aurilia C; Grazzi L; Vernieri F; Altamura C; Camarda C; Torelli P; Cevoli S; Russo A; Bono F; Finocchi C; Rao R; Messina S; De Simone R; D'Onofrio F; Aguggia M; Frediani F; Carnevale A; Autunno M; Lia C; Battista Allais G; Coppola A; Perini F; Balsamo P; Strumia S; Colombo B; Proietti S; et alii...

The Italian chROnic migraiNe (IRON) registry: First report from 28 headache centers in Journal of Headache and Pain

2018
ASL Asti
AOU Città della Salute di Torino
ASL Cuneo 2
ASL Torino 3

Barbanti P; Fofi L; Egeo G; Aurilia C; Cevoli S; Pierangeli G; Torelli P; Manzoni G; Camarda C; Grazzi L; D'Amico D; Vernieri F; Balsamo P; Frediani F; D'Arrigo G; Di Fiore P; Finocchi C; Perini F; D'Onofrio F; Bono F; Russo A; De Simone R; Ferra G; Busillo V; Carnevale A; Pierelli F; Di Lorenzo C; Valguarnera F; Rao R; et alii...